Reviva Pharmaceuticals Holdings, Inc. (RVPH)
USD 1.44
(2.5%)
USD 1.44
(2.5%)
| Breakdown | 2022 | 2021 | 2020 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -18.96 Million | -10.66 Million | -3.72 Million | -218.44 Thousand |
| Net Income | -24.33 Million | -8.52 Million | -3.78 Million | -846.83 Thousand |
| Depreciation & Amortization | - | - | 591.00 | 645.00 |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 176.73 Thousand | 106.71 Thousand | - | - |
| Change in working capital | 5 Million | -702.17 Thousand | -2.32 Million | 634.15 Thousand |
| Other non-cash items | 194.7 Thousand | -1.55 Million | 2.38 Million | -6409.00 |
| Investing Cash Flow | - | - | - | - |
| Investments in PPE | - | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 7.79 Million | 31.59 Million | 12.82 Million | 100 Thousand |
| Debt repayment | - | - | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 7.77 Million | 31.49 Million | - | - |
| Other Financing Activities | 18.96 Thousand | 98.48 Thousand | 12.82 Million | - |
| Accounts receivables | - | - | - | - |
| Accounts payables | 3.01 Million | -498.46 Thousand | 775.1 Thousand | 158.17 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 1.99 Million | -203.71 Thousand | -3.1 Million | 475.98 Thousand |
| Cash at beginning of period | 29.68 Million | 8.76 Million | 193.00 | 118.63 Thousand |
| Cash at end of period | 18.51 Million | 29.68 Million | 8.76 Million | 193.00 |
| Capital Expenditure | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | -11.16 Million | 20.92 Million | 8.76 Million | -118.44 Thousand |
| Free Cash Flow | -18.96 Million | -10.66 Million | -3.72 Million | -218.44 Thousand |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.44 Million | -6.6 Million | -24.33 Million | -8.11 Million | -3.51 Million | -5.34 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.62 Million | 51.52 Thousand | 176.73 Thousand | 56.58 Thousand | 40.58 Thousand | 39.87 Thousand |
| Change in working capital | 4.04 Million | -1.38 Million | 5 Million | 2.9 Million | -527.27 Thousand | 1.47 Million |
| Other non-cash items | 456.17 Thousand | -11.12 Thousand | 194.7 Thousand | 461.74 Thousand | - | -178.02 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.21 Million | 687.09 Thousand | 7.79 Million | 18.56 Thousand | 7.77 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 7.77 Million | 7.76 Billion | 7.77 Million | - |
| Other Financing Activities | - | 687.09 Thousand | 18.96 Thousand | -7.76 Billion | 333.00 | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -212.29 Thousand | -659.69 Thousand | 3.01 Million | 1.38 Million | -243.66 Thousand | 1.19 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.26 Million | 659.69 Thousand | 1.99 Million | 1.52 Million | -283.6 Thousand | 278.27 Thousand |
| Cash at beginning of period | 11.25 Million | 18.51 Million | 29.68 Million | 23.19 Million | 19.42 Million | 23.42 Million |
| Cash at end of period | 11.15 Million | 11.25 Million | 18.51 Million | 18.51 Million | 23.19 Million | 19.42 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -103.97 Thousand | -7.26 Million | -11.16 Million | -4.67 Million | 3.77 Million | -4 Million |
| Free Cash Flow | -5.31 Million | -7.95 Million | -18.96 Million | -4.69 Million | -4 Million | -4 Million |
MET-PF
6046
QGTS
SANJIVIN
LWLG
2668